CoChat

Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome‐Conjugated Magnetic Nanoparticles for Glioblastoma Therapy

Open access
Li, Boyan, Chen, Xin, Qiu, Wei, Zhao, Rongrong, Duan, Jiazhi, Zhang, Shouji, Pan, Ziwen, Zhao, Shulin, Guo, Qindong, Qi, Yanhua, Wang, Wenhan, Deng, Lin, Ni, Shilei, Sang, Yuanhua, Xue, Hao, Liu, Hong, Li, Gang · 2022 · Advanced Science
Cited by 201

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Glioblastoma (GBM) is one of the most fatal central nervous system tumors and lacks effective or sufficient therapies. Ferroptosis is a newly discovered method of programmed cell death and opens a new direction for GBM treatment. However, poor blood–brain barrier (BBB) penetration, reduced tumor targeting ability, and potential compensatory mechanisms hinder the effectiveness of ferroptosis agents during GBM treatment. Here, a novel composite therapeutic platform combining the magnetic targeting features and drug delivery properties of magnetic nanoparticles with the BBB penetration abilities and siRNA encapsulation properties of engineered exosomes for GBM therapy is presented. This platform can be enriched in the brain under local magnetic localization and angiopep‐2 peptide‐modified engineered exosomes can trigger transcytosis, allowing the particles to cross the BBB and target GBM cells by recognizing the LRP‐1 receptor. Synergistic ferroptosis therapy of GBM is achieved by the combined triple actions of the disintegration of dihydroorotate dehydrogenase and the glutathione peroxidase 4 ferroptosis defense axis with Fe 3 O 4 nanoparticle‐mediated Fe 2+ release. Thus, the present findings show that this system can serve as a promising platform for the treatment of glioblastoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202105451

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 201

Metadata

Authors
Li, B., Chen, X., Qiu, W., Zhao, R., Duan, J., Zhang, S., Pan, Z., Zhao, S., Guo, Q., Qi, Y., Wang, W., Deng, L., Ni, S., Sang, Y., Xue, H., Liu, H., & Li, G.
Venue
Advanced Science
Publisher
Wiley
Published
2022-05-04
Volume
9
Issue
17
Pages
e2105451-e2105451
ISSN
2198-3844 (ISSN-L)
OpenAlex
W4229040449
Cited by
201
References
12
FWCI
9.50
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome‐Conjugated Magnetic Nanoparticles for Glioblastoma Therapy. https://app.cochat.ai/papers/10.1002/advs.202105451
The paper
Li, B., Chen, X., Qiu, W., Zhao, R., Duan, J., Zhang, S., Pan, Z., Zhao, S., Guo, Q., Qi, Y., Wang, W., Deng, L., Ni, S., Sang, Y., Xue, H., Liu, H., & Li, G. (2022). Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome‐Conjugated Magnetic Nanoparticles for Glioblastoma Therapy. Advanced Science. https://doi.org/10.1002/advs.202105451

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.